Cargando…
Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination
Background: We herein report two cases of sudden onset symptomatic pulmonary hypertension after coronavirus disease 2019 (COVID-19) vaccination. Case Summary: Pulmonary hypertension in previously healthy adult males occurred within three weeks of receiving the second dose of the Pfizer (BNT162b2) mR...
Autores principales: | Sullivan, Robert D., Shults, Nataliia V., Suzuki, Yuichiro J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528902/ https://www.ncbi.nlm.nih.gov/pubmed/37754310 http://dx.doi.org/10.3390/diseases11030114 |
Ejemplares similares
-
Oxidative profiling of the failing right heart in rats with pulmonary hypertension
por: Wang, Xinhong, et al.
Publicado: (2017) -
Apoptosis-based therapy to treat pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2016) -
Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine
por: Sciaccaluga, Carlotta, et al.
Publicado: (2022) -
COVID-19 patients may become predisposed to pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2021) -
Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports
por: Mohamed, Libin, et al.
Publicado: (2021)